|Bid||47.63 x 1000|
|Ask||47.66 x 900|
|Day's range||47.05 - 47.92|
|52-week range||34.98 - 48.87|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||112.74|
|Earnings date||25 Apr 2023 - 01 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||52.76|
Boston Scientific's (BSX) organic revenues at each of its core business segments and geographies increase in the fourth quarter of 2022.
Boston Scientific (BSX) delivered earnings and revenue surprises of -4.26% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Medical device companies' results are likely to reflect a sequential decline. Let's see how BSX, TMO, HOLX and ALGN fare this time.